Evidence map›Paper›PMID 38269589›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2024

Profibrotic VEGFR3-Dependent Lymphatic Vessel Growth in Autoimmune Valvular Carditis.

Victoria Osinski, Amritha Yellamilli, Maria M Firulyova, Michael J Zhang, Alyssa L Peck, Jennifer L Auger, Jessica L Faragher, Aubyn Marath, Rochus K Voeller, Timothy D O'Connell and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Lymphatic therapies open the valve in Marfan syndrome.The Journal of clinical investigation · 2026
    Article
  3. Valve biology and rheumatic heart disease pathogenesis.Nature cardiovascular research · 2026
    Review
  4. Article
  5. Normal cardiac lymphatics and their mimics.American journal of physiology. Heart and circulatory physiology · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Victoria OsinskiDepartment of Pediatrics and Center for Immunology (V.O., A.L.P., J.L.A., J.L.F., B.A.B.), University of Minnesota, Minneapolis.ORCID 0000-0002-8969-8454
Amritha YellamilliMedical Scientist Training Program (A.Y.), University of Minnesota, Minneapolis.
Maria M FirulyovaAlmazov National Medical Research Centre, Saint Petersburg, Russia (M.M.F.).ORCID 0000-0002-4839-5115
Michael J ZhangDepartment of Integrative Biology and Physiology (M.J.Z., T.D.O.), University of Minnesota, Minneapolis.ORCID 0000-0003-2537-2831
Alyssa L PeckDepartment of Pediatrics and Center for Immunology (V.O., A.L.P., J.L.A., J.L.F., B.A.B.), University of Minnesota, Minneapolis.
Jennifer L AugerDepartment of Pediatrics and Center for Immunology (V.O., A.L.P., J.L.A., J.L.F., B.A.B.), University of Minnesota, Minneapolis.ORCID 0000-0003-2707-7561
Jessica L FaragherDepartment of Pediatrics and Center for Immunology (V.O., A.L.P., J.L.A., J.L.F., B.A.B.), University of Minnesota, Minneapolis.ORCID 0000-0001-7593-3524
Aubyn MarathCardioStart International, Tampa, FL (A.M.).ORCID 0000-0003-2300-1674
Rochus K VoellerDepartment of Surgery (R.K.V.), University of Minnesota, Minneapolis.ORCID 0009-0005-8077-8916
Timothy D O'ConnellDepartment of Integrative Biology and Physiology (M.J.Z., T.D.O.), University of Minnesota, Minneapolis.
Konstantin ZaitsevComputer Technologies Laboratory, ITMO (University of Information Technologies, Mechanics and Optics) University, Saint Petersburg, Russia (M.M.F., K.Z.).ORCID 0000-0003-3749-0886
Bryce A BinstadtDepartment of Pediatrics and Center for Immunology (V.O., A.L.P., J.L.A., J.L.F., B.A.B.), University of Minnesota, Minneapolis.ORCID 0000-0003-3127-3856
University of Minnesota · USITMO University · RUStart International · USUniversity of Minnesota Medical Center · US

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008244 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SHIMIZU, YOJI · 1988 to 2024
$13.6M
Pathogenesis of autoimmune valvular carditisR01HL121093 · NHLBI · UNIVERSITY OF MINNESOTA · PI BINSTADT, BRYCE · 2014 to 2023
$3.8M
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injuryR01HL152215 · NHLBI · UNIVERSITY OF MINNESOTA · PI O'CONNELL, TIMOTHY D, SHEARER, GREGORY C · 2020 to 2024
$3.4M
Training Program in Cardiac InnovationT32HL144472 · NHLBI · UNIVERSITY OF MINNESOTA · PI Peter A Crawford, SAMUEL C DUDLEY · 2019 to 2026
$2.6M
Mechanisms of free fatty acid receptor 4 signaling in the ischemic myocardiumF32HL152523 · NHLBI · UNIVERSITY OF MINNESOTA · PI ZHANG, MICHAEL JINGYUAN · 2020 to 2021
$143k
Determining the functions of LYVE1 on macrophages during autoantibody-induced valve diseaseF32HL165694 · NHLBI · UNIVERSITY OF MINNESOTA · PI OSINSKI, VICTORIA · 2022 to 2023
$94k
NCATS NIH HHS UL1 TR002494NHLBI NIH HHS F32 HL152523NHLBI NIH HHS F32 HL165694NHLBI NIH HHS R01 HL121093NHLBI NIH HHS R01 HL152215NHLBI NIH HHS T32 HL144472NIGMS NIH HHS T32 GM008244
6 · The paper itself

Abstract

backgroundRheumatic heart disease is the major cause of valvular heart disease in developing nations. Endothelial cells (ECs) are considered crucial contributors to rheumatic heart disease, but greater insight into their roles in disease progression is needed.

methodsWe used a

resultsLineage tracing in K/B.g7 mice revealed new capillary lymphatic vessels arising from valve surface ECs during the progression of disease in K/B.g7 mice. Unsupervised clustering of mitral valve single-cell RNA-sequencing data revealed novel lymphatic valve ECs that express a transcriptional profile distinct from other valve EC populations including the recently identified PROX1 (Prospero homeobox protein 1)+ lymphatic valve ECs. During disease progression, these newly identified lymphatic valve ECs expand and upregulate a profibrotic transcriptional profile. Inhibiting VEGFR3 through multiple approaches prevented expansion of this mitral valve lymphatic network. Echocardiography demonstrated that K/B.g7 mice have left ventricular dysfunction and mitral valve stenosis. Valve lymphatic density increased with age in K/B.g7 mice and correlated with worsened ventricular dysfunction. Importantly, human rheumatic valves contained similar lymphatics in greater numbers than nonrheumatic controls.

conclusionsThese studies reveal a novel mode of inflammation-associated, VEGFR3-dependent postnatal lymphangiogenesis in murine autoimmune valvular carditis, with similarities to human rheumatic heart disease.

Indexed as

Heart Valve DiseasesLymphatic VesselsMyocarditisRheumatic Heart DiseaseAnimalsDisease ProgressionEndothelial CellsHumansMiceRNAVascular Endothelial Growth Factor AVascular Endothelial Growth Factor CVascular Endothelial Growth Factor Receptor-3RNAVascular Endothelial Growth Factor AVascular Endothelial Growth Factor CVascular Endothelial Growth Factor Receptor-3echocardiographyendothelial cellsheart valve diseasesinflammationlymphangiogenesis

Identifiers

PMID38269589
PMCPMC10978259
OpenAlexW4391225516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.